Palo Alto Investors »

Inspire Med Sys shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Inspire Med Sys (INSP) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Inspire Med Sys

Tip: Access up to 7 years of quarterly data

All positions including Inspire Med Sys held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inspire Med Sys by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $453k 8.8k 51.58
2025-12-31 $809k 8.8k 92.23

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Inspire Med Sys

BlackRock
Vanguard Group
Deerfield Management Company
Wellington Management Company
Vanguard Portfolio Management
Morgan Stanley
Vanguard Capital Management
D. E. Shaw & Co
William Blair Investment Management
State Street Corporation
Artisan Partners Limited Partnership
Braidwell
Goldman Sachs Group
UBS Group
Soleus Capital Management

View all funds holding Inspire Med Sys